Literature DB >> 19520590

MicroRNA and leukemia: tiny molecule, great function.

Haifeng Zhao1, Donghai Wang, Weiting Du, Dongsheng Gu, Renchi Yang.   

Abstract

MicroRNAs are small noncoding RNA molecules that negatively regulate gene expression via degradation or translational repression of their targeted messenger RNAs (mRNAs). It is known that aberrant microRNA expression can play a vital role in the pathology of leukemia, thus microRNAs have rapidly emerged as potential targets for therapeutics. This review focuses on recent researches on the important roles of microRNAs in the pathogenesis of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520590     DOI: 10.1016/j.critrevonc.2009.05.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  28 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 2.  Environmental chemicals and microRNAs.

Authors:  Lifang Hou; Dong Wang; Andrea Baccarelli
Journal:  Mutat Res       Date:  2011-05-14       Impact factor: 2.433

3.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 4.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

Review 5.  MicroRNA theragnostics for the clinical management of multiple myeloma.

Authors:  N Ahmad; S Haider; S Jagannathan; E Anaissie; J J Driscoll
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

6.  Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2'-deoxycytidine by targeting miR-9.

Authors:  F Li; W He; R Geng; X Xie
Journal:  Clin Transl Oncol       Date:  2019-05-03       Impact factor: 3.405

Review 7.  Polycomb group proteins and MYC: the cancer connection.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2013-07-30       Impact factor: 9.261

Review 8.  MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia.

Authors:  Su Jung Song; Pier Paolo Pandolfi
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

9.  miR-139 acts as a tumor suppressor in T-cell acute lymphoblastic leukemia by targeting CX chemokine receptor 4.

Authors:  Ling Qin; Hui-Yang Deng; Sheng-Jiang Chen; Wei Wei; Yi-Ting Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 10.  Aberrant microRNA expression and its implications in the pathogenesis of leukemias.

Authors:  Sadegh Babashah; Majid Sadeghizadeh; Mostafa Rezaei Tavirani; Shirin Farivar; Masoud Soleimani
Journal:  Cell Oncol (Dordr)       Date:  2012-09-07       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.